Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKGP.L Regulatory News (KGP)

  • There is currently no data for KGP

Interim Management Statement

9 Nov 2015 07:00

RNS Number : 9286E
Kingspan Group PLC
09 November 2015
 

Kingspan Group plc

Interim Management Statement

 

 

9 November 2015

 

Kingspan Group plc, the global leader in high performance insulation and building envelope solutions, today issues an Interim Management Statement, with trading information for the period to 30 September 2015.

Sales in the nine month period to 30 September were €2.0bn, up 44% on the comparable period in the prior year (+34% pre currency). A strong sales performance was recorded in the third quarter boosted by the contribution from acquisitions with sales up 54% (+46% pre currency). Underlying sales, pre currency and acquisitions, were up 3% both in the year to date and third quarter.

Insulated Panel sales in the first nine months increased by 54% (+46% pre currency), and by 73% (+65% pre currency) in the third quarter. Underlying sales were 4% ahead year to date and by 5% in the third quarter. The UK continues to perform solidly, albeit with some moderation since September. Mainland Europe recorded a steady sales performance overall with reasonable activity in most key markets. North American sales have grown strongly in the year to date with the US outpacing Canada, which has been more variable. Activity in Australasia has stabilised more recently although year to date sales are behind the prior year.

Insulation Board sales in the first nine months were up 39% (+29% pre currency) and by 38% in quarter three (+29% pre currency). Underlying sales growth, pre currency and acquisitions, was 4% year to date and 1% in the third quarter. In particular, the pace of sales growth in certain segments of the UK market has moderated since late summer and we have seen a decline in sales in Australia in a tighter market. Mainland European sales have been relatively stable overall, and growing in the Benelux, whilst North American sales continue to progress positively.

Environmental sales in the first nine months and in the third quarter were up 8% (-1% pre currency). The trend of improvement in profitability evident in the first half has continued in the period since.

Access Floors sales in the first nine months increased by 17% (+1% pre currency). Sales in the third quarter increased by 9% (-3% pre currency). The US office market has been softer in more recent months, albeit relatively stable at current levels.

Net debt at the end of September 2015 was €413.8m, which is €306.1m higher than at the same point in 2014 due to acquisition activity year on year. Net debt at year end is forecast to be in the region of €380m.

 

2015 to date has been a significant period for Kingspan with a further step up in the breadth of the Group providing strong channels for future growth in market penetration. Integration of both the Joris Ide and VicWest businesses remains fully on track. Group underlying sales have shown c. 3% growth for much of the year with individual markets trending differently. Considering our current orderbook, this revenue pattern is likely to continue over the coming months. Profitability has benefitted from strong operating leverage, and has been further complemented by unusually favourable exchange rates and a positive input cost environment.

 

Assuming current exchange rates prevail, we expect to deliver a full year trading profit of approximately €250m (+68% versus 2014), cognisant that much of the seasonally variable fourth quarter remains. We are also mindful that the first quarter of 2016 will include the full weakness of the winter season for the businesses acquired this year, and which were not consolidated in the Group's results in the early part of 2015.

 

For further information contact:

 

Gene Murtagh, Chief Executive Officer Tel: +353 (0) 42 9698000

 

Geoff Doherty, Chief Financial Officer Tel: +353 (0) 42 9698000

 

Douglas Keatinge, Murray Consultants Tel: +353 (0) 1 4980300

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSBLBDBRSGBGUL
Date   Source Headline
6th Jan 20215:12 pmRNSHolding(s) in Company
5th Jan 20214:03 pmRNSHolding(s) in Company
4th Jan 202110:00 amRNSBlock listing Interim Review
4th Jan 20219:00 amRNSTotal Voting Rights
17th Dec 20209:00 amRNSDirectorate Change
1st Dec 20204:12 pmRNSTotal Voting Rights
16th Nov 20207:00 amRNSTrading Statement
2nd Nov 20201:04 pmRNSDirector/PDMR Shareholding
2nd Nov 202012:19 pmRNSTotal Voting Rights
15th Oct 20205:04 pmRNSDirector/PDMR Shareholding
14th Oct 20201:05 pmRNSDirector/PDMR Shareholding
1st Oct 202012:42 pmRNSTotal Voting Rights
29th Sep 20202:32 pmRNSDirector/PDMR Shareholding
15th Sep 20207:00 amRNSGreen Private Placement
1st Sep 20203:44 pmRNSTotal Voting Rights
24th Aug 20205:34 pmRNSDirector/PDMR Shareholding
24th Aug 20205:27 pmRNSDirector/PDMR Shareholding
21st Aug 20207:00 amRNSHalf-year Report
1st Jul 20206:17 pmRNSBlock listing Interim Review
1st Jul 202011:27 amRNSTotal Voting Rights
25th Jun 20203:44 pmRNSHolding(s) in Company
17th Jun 20204:51 pmRNSHolding(s) in Company
2nd Jun 20203:00 pmRNSTotal Voting Rights
1st May 20203:20 pmRNSResult of AGM
1st May 20209:45 amRNSTotal Voting Rights
30th Apr 20207:00 amRNSTrading Statement
17th Apr 20204:11 pmRNSHolding(s) in Company
17th Apr 20207:00 amRNSStatement re AGM
14th Apr 202011:41 amRNSHolding(s) in Company
1st Apr 202012:46 pmRNSTotal Voting Rights
30th Mar 202011:37 amRNSHolding(s) in Company
23rd Mar 202011:05 amRNSHolding(s) in Company
19th Mar 202012:00 pmRNSDividend Declaration
18th Mar 20209:15 amRNSHolding(s) in Company
2nd Mar 20202:23 pmRNSTotal Voting Rights
28th Feb 202010:38 amRNSAnnual Financial Report
26th Feb 20204:54 pmRNSDirector/PDMR Shareholding
24th Feb 20205:49 pmRNSHolding(s) in Company
24th Feb 20202:26 pmRNSDirector/PDMR Shareholding
24th Feb 202010:10 amRNSDirector/PDMR Shareholding
21st Feb 20207:00 amRNSFinal Results
20th Jan 20209:50 amRNSHolding(s) in Company
3rd Jan 20205:21 pmRNSHolding(s) in Company
2nd Jan 202011:00 amRNSBlock listing Interim Review
2nd Jan 202010:00 amRNSTotal Voting Rights
17th Dec 201910:45 amRNSDirector/PDMR Shareholding
11th Dec 20195:40 pmRNSDirector/PDMR Shareholding
2nd Dec 20192:58 pmRNSTotal Voting Rights
18th Nov 20197:00 amRNSTrading Update
5th Nov 201912:43 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.